Tech Company Financing Transactions
Stramsen Biotech Funding Round
Stramsen Biotech closed a $25 million funding round on 4/7/2025. Investors included Global Emerging Markets and private investors.
Transaction Overview
Company Name
Announced On
4/7/2025
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Global Emerging Markets (Lead Investor)
Proceeds Purpose
The company intends to use the funds to: Accelerate global expansion initiatives, Prepare for prospectus submission and pursue an Initial Public Offering (IPO), consolidating its financial position and market visibility. Invest in research and development of 33 new drug candidates. Initiate the submission of multiple Investigational New Drug (IND) applications with the Food and Drug Administration (FDA), advancing its pipeline towards clinical trials. Establish a distinguished Scientific Advisory Board and expand its team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5718 Westheimer Road, 10th Floor 1000
Houston, TX 77057
USA
Houston, TX 77057
USA
Phone
Website
Email Address
Overview
At Stramsen Biotech Inc., our mission is to revolutionize health, performance, and well-being through groundbreaking research and development of plant-based medicines. We are committed to transforming patients' lives with our innovative approach, backed by a robust pipeline of 33 plant-based drug candidates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kefas Mugittu
Browse more venture capital transactions:
Prev: 4/7/2025: CalligoTech venture capital transaction
Next: 4/7/2025: Krea venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs